The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
but everything got better in this individual his metabolic sensitivity got better his dementia improved based on his mocha rating and he lost weight so at least in this case study we can substantiate or begin to look with more favorability toward the notion that apoe4 does not mean dementia necessarily
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
this individual was given a diet high in saturated fats and low in carbohydrates again he was heterozygous for apoe4 he was type 2 diabetic and they say that at the end of the intervention this is just one case study the patient's mocha montreal cognitive assessment improved from 23 out of 30 to 29 out of 30. normal is greater than 26 his type 2 diabetes reversed his pre-intervention hemoglobin a1c was 7.8 post-intervention a1c 5.5 patient achieves statistically significant improvements in markers of metabolic syndrome